SBIA Webinars
2021 Webinars
- Clinical Investigator Training Course (CITC) Update - 12/07/2021 - 12/08/2021
- Enhanced Drug Distribution Security in 2023 Under the DSCSA - Oct. 5, 2021
- Investigator Responsibilities — Safety Reporting for Investigational Drugs and Device - September 30,2021
- Promotional Submissions in eCTD Format – Grouped Submissions - Aug. 31, 2021
- Manufacturing, Supply Chain, and Inspections during the COVID19 Public Health Emergency - Aug.25, 2021
- Identification of Medicinal Products: Path to Global Implementation - June 11, 2021
- OTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2021 User Fees Webinar - 06/03/2021 - 06/03/2021
- FDA and Health Canada Regional ICH Consultation - May 24, 2021
- FDA Study Data Technical Rejection Criteria (TRC): What you need to know! - May 21, 2021
- FDA Product-Specific Guidances: Lighting the Development Pathway for Generic Drugs - May 5, 2021
- Common Labeling Deficiencies and Tips for Generic Drug Applications - May 7, 2021
- Drug Master File (DMF) and Drug Substance Question and Answer Webinar Following March 3-4, 2021 Workshop - April 9, 2021
- FDA Safety Report Type Flag Requirement for FAERS Submissions - February 29, 2021
- Regulatory Perspectives for Development of Drugs for Treatment of NASH - January 29, 2021
- OTC Monograph Reform in the CARES Act: Safety Orders - January 27, 2021
- Drug Master File (DMF) Submissions on New FDA Form 3938 - January 13, 2021
2020 Webinars
- Diversity in Clinical Trials: Learn about Enrollment Trends and Resources from FDA - December 16, 2020
- SEND for CBER, What You Need to Know - December 4, 2020
- Guidance for Industry: Referencing Approved Drug Products in ANDA Submissions - November 20, 2020
- Office of Prescription Drug Promotion - Core Launch Review Process - November 20, 2020
- Bridging the Gap – Promoting Safe and Effective Prescription Drug Use in Geriatric Patients - November 13, 2020
- SBIA Webinar: FDA Announces Quality Management Maturity Programs - November 12, 2020
- Office of New Drug (OND) Research: Seeking Collaborators, Funding Opportunities Available - November 6, 2020
- New Approaches for an Integrated Nonclinical-Clinical QT/Proarrhythmic Risk Assessment - October 15-16, 2020
- Overview of the Guidance for Industry: Control of Nitrosamine Impurities in Human Drugs - October 2, 2020
- Cannabis Clinical Research: Drug Master Files (DMFs) & Quality Considerations - September 16, 2020
Archive
2011-2015 webinar pages are archived. To view them, please see the FDA Archive.
To view the webinars, copy and paste the web address starting with https:// into a web browser.
To view the webinars, copy and paste the web address starting with https:// into a web browser.